Pranita Tamma
Dr. Tamma is an Associate Professor of Pediatrics and the Director of the Pediatric Antimicrobial Stewardship Program at The Johns Hopkins University School of Medicine. She is also an Associate Professor in the Department of Epidemiology at The Johns Hopkins Bloomberg School of Public Health. Her research focuses on: (a) elucidating the mechanisms of resistance in gram-negative organisms, (b) developing and enhancing laboratory methods to identify gram-negative resistant organisms to enable critically-ill patients to be placed on appropriate antibiotic therapy as early as possible, and (c) identifying optimal treatment strategies for patients infected with multidrug-resistant gram-negative infections. She is an Editor at Antimicrobial Agents and Chemotherapy, a voting member of the Clinical Laboratory and Standards Institute Antibiotic Susceptibility Testing Subgroup that provides international guidance on establishing antibiotic breakpoints and phenotypic and genotypic methods for identifying antimicrobial resistance, a voting member of the NIH-funded Antibacterial Resistance Leadership Group Gram-Negative Resistance Committee, and the lead author of the Infectious Diseases Society of America Antimicrobial Resistance Treatment Guidance.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:12/12/2023Date updated:12/12/2023
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward